News & Updates

In patients with mild autonomous cortisol secretion (MACS), overnight metyrapone therapy helps to partially retore hypothalamic-pituitary-adrenal (HPA) axis balance and improve sleep and mood, with a favourable tolerability profile, according to a phase II trial.

Subcutaneous injections of olatorepatide, an investigational dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, are associated with up to a 19-percent decrease in body weight and favourable gastrointestinal (GI) tolerability in Chinese adults with overweight or obesity, as shown in the phase III LIGHTEN study.

Among people living with HIV who are initiating antiretroviral therapy (ART), those with obesity potentially face a higher long-term risk of cardiovascular disease (CVD), cancer, or death, according to an observational study.

New drug applications approved by US FDA as of 16-30 September 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

New drug applications approved by US FDA as of 1-15 September 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Regular consumption of fast foods, confectionery, fried potatoes, sauces, sugar-sweetened beverages, and refined grains appears to increase the risks of depression and anxiety in adults, suggests a study.

A positive association exists between early pregnancy metabolomic signatures and child growth acceleration, a study has shown.

As Hong Kong’s population ages, osteoporosis has emerged as a significant health concern, currently affecting an estimated 400,000 individuals. The rising incidence of osteoporotic or fragility fractures contributes to increased morbidity and mortality, creating a substantial burden on the healthcare system. At a scientific symposium, experts in cardiology, orthopaedic surgery, geriatrics, endocrinology, and anaesthesiology explored how a multidisciplinary approach can enhance the management of fragility fractures, particularly hip fractures. The discussions focused on optimizing care from the point of admission through to recovery, with an emphasis on postoperative prevention of imminent fractures using an osteoanabolic-first approach to improve patient outcomes.